MedTrace Logo

Targeted Genomic Analysis of Blood and Tissue Samples From Patients With Cancer

NCT02688517 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 1100

Last updated 2026-04-17

No results posted yet for this study

Summary

This research trial studies the use of targeted genomic analysis of blood and tissue samples from patients with cancer. Genomic sequencing is a laboratory method that is used to determine the entire genetic makeup of a specific organism or cell type. Genomic sequencing can be used to find changes in areas of the genome that may be important in the development of cancer. It may also help doctors improve ways to diagnose and treat patients with rare cancers with poor prognosis or lack of effective therapy.

Conditions

  • Malignant Neoplasm

Interventions

OTHER

Cytology Specimen Collection Procedure

Undergo collection of blood samples

OTHER

Laboratory Biomarker Analysis

Correlative studies

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH

  • Rutgers Cancer Institute of New Jersey

    collaborator OTHER

  • Rutgers, The State University of New Jersey

    lead OTHER

Principal Investigators

  • Shridar Ganesan · Rutgers Cancer Institute of New Jersey

Eligibility

Min Age
1 Year
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-02-28
Primary Completion
2030-05-31
Completion
2030-05-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02688517 on ClinicalTrials.gov